These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 4988185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The problem of active immunization against measles.
    Chumakov MP.
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):381-8. PubMed ID: 4975393
    [No Abstract] [Full Text] [Related]

  • 3. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
    [No Abstract] [Full Text] [Related]

  • 4. Sensitization of guinea-pigs to measles vaccines.
    Aprile MA, Kadar D, Wilson S.
    Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
    Sasaki K.
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Results of testing the effectiveness of live measles virus vaccine by using measles reference virus M1].
    Winkler D, Starke G, Patzwaldt HG, Plaga B.
    Pharmazie; 1972 Sep; 27(9):606-8. PubMed ID: 5086359
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of host-incorporated antigens in the immune response to measles virus.
    Isacson P.
    Int Arch Allergy Appl Immunol; 1969 Sep; 36():Suppl:139-45. PubMed ID: 4313661
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Specific prophylaxis in measles. I. Preparation of a vaccine with modified live virus (strain M60-5 Huang)].
    Cajal N, Cepleanu M, Sorodoc Y.
    Stud Cercet Inframicrobiol; 1966 Sep; 17(5):371-6. PubMed ID: 5964005
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain.
    Ueda S, Takahashi M, Minekawa Y, Ogino T, Suzuki N.
    Biken J; 1970 Jun; 13(2):111-6. PubMed ID: 5528344
    [No Abstract] [Full Text] [Related]

  • 15. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM, Titova NS.
    Sov Med; 1981 Jun; (9):43-8. PubMed ID: 7313794
    [No Abstract] [Full Text] [Related]

  • 16. [Potency test of measles vaccines from inactivated viruses. II. Calculation by a new estimating formula].
    von Mettenheim AE.
    Zentralbl Bakteriol Orig; 1968 Jun; 207(2):158-65. PubMed ID: 5744277
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S, Takahashi M, Kurimura T, Ogino T, Suzuki N.
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.